Characterization and therapeutic application of canine adipose mesenchymal stem cells to treat elbow osteoarthritis

• Published in: Canadian journal of veterinary research 2017-01, Vol.81 (1), p.73-78
• Main Authors: Kriston-Pál, Éva, Czibula, Ágnes, Gyuris, Zoltán, Balka, Gyula, Seregi, Antal, Sükösd, Farkas, Süth, Miklós, Kiss-Tóth, Endre, Haracska, Lajos, Uher, Ferenc, Monostori, Éva
• Format: Article
• Language: English
• ISSN: 0830-9000; 1928-9022

Visceral adipose tissue (AT) obtained from surgical waste during routine ovariectomies was used as a source for isolating canine mesenchymal stem cells (MSCs). As determined by cytofluorimetry, passage 2 cells expressed MSC markers CD44 and CD90 and were negative for lineage-specific markers CD34 and CD45. The cells differentiated toward osteogenic, adipogenic, and chondrogenic directions. With therapeutic aims, 30 dogs (39 joints) suffering from elbow dysplasia (ED) and osteoarthritis (OA) were intra-articularly transplanted with allogeneic MSCs suspended in 0.5% hyaluronic acid (HA). A highly significant improvement was achieved without any medication as demonstrated by the degree of lameness during the follow-up period of 1 y. Control arthroscopy of 1 transplanted dog indicated that the cartilage had regenerated. Histological analysis of the cartilage biopsy confirmed that the regenerated cartilage was of hyaline type. These results demonstrate that transplantation of allogeneic adipose tissue-derived mesenchymal stem cells (AT-MSCs) is a novel, noninvasive, and highly effective therapeutic tool in treating canine elbow dysplasia.